M&A · Healthcare · Buyer's industry: In Vitro & In Vivo Diagnostic Substances
Meridian Bioscience Inc to acquire Urea Breath Test
Announced Jul 23, 2021 · Announced · Private target
Deal value$20M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- Meridian Bioscience Inc
- Target
- Urea Breath Test
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Announced
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- In Vitro & In Vivo Diagnostic Substances